Source: Annual Congress 2006 - Focus of care for tomorrow's allied health professionals
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
A. F. Schoonis, N. Cuvillier, C. Lodewijckx, B. Bouckaert, G. M. Verleden (Leuven, Belgium). Comparison of carbon monoxide (CO) monitoring to urine cotinine (COT) analysis to detect tobacco use in lung transplant recipients. Eur Respir J 2006; 28: Suppl. 50, 841

Member's Comments

No comment yet.

Related content which might interest you: Usefulness of the determination of carbon monoxide in exhaled air (COEA) in second hand and direct exposure to tobacco smoke during childhood and adolescence Source: Annual Congress 2009 - Smoking habits and prevention in young people Year: 2009 Investigation of the relationship between contents of carboxyhemoglobin (COHb) in blood and carbon monoxide (CO) in exhaled air Source: Eur Respir J 2005; 26: Suppl. 49, 261s Year: 2005 Exhaled carbon monoxide as a marker of tobacco exposure: is it possible to use the same parameters in COPD patients? Source: Eur Respir J 2006; 28: Suppl. 50, 389s Year: 2006 Analysis of carbon monoxide in the breathable air by the breath CO method for risk assessment of indoor CO exposure and comparison with COHb measurement in blood samples Source: Annual Congress 2010 - Outdoor air pollution Year: 2010 Comparison of end tidal carbon monoxide (eCO) levels in shisha (water pipe) and cigarette smokers Source: Annual Congress 2012 - Tobacco and shisha exposure in children and adolescents Year: 2012 Correlations between lung function, exhaled carbon monoxide and „lung age” in smokers versus former smokers with COPD Source: International Congress 2017 – Smoking and health hazards Year: 2017 Measurement of urinary cotinine and exhaled air carbon monoxide levels among active, passive smoker and non-smoker health staff Source: Eur Respir J 2006; 28: Suppl. 50, 470s Year: 2006 Comparison of serum and urine cotinine level according to stage exhaled CO in smokers Source: Virtual Congress 2021 – Health effects of tobacco and medical professionals Year: 2021 Effect of the presence of lung cancer on diffusion capacity of carbon monoxide in a cohort of smokers Source: Annual Congress 2010 - Thoracic malignancies: interesting case studies and series Year: 2010 Effects of water-pipe (narghile) smoking on exhaled carbon monoxide levels Source: Annual Congress 2009 - Tobacco: from smoke to disease Year: 2009 Non-invasive method for investigation of inhaled carbon monoxide (CO) distribution between intra- and extravascular compartments Source: Annual Congress 2011 - Lung function today and tomorrow I Year: 2011 Diagnostic value of lung diffusion capacity asymmetry for carbon monoxide (CO) Source: Annual Congress 2010 - Advances in lung function I Year: 2010 Alcohol effects on diffusing capacity of the lung for carbon monoxide (DLCO) in healthy subjects and in COPD patients Source: Annual Congress 2010 - Exercise in respiratory diseases and oxygen therapy Year: 2010 Comparison of exhaled carbon monoxide between patients with high dose and lowdose exposure to mustard gas Source: Annual Congress 2008 - The biology of smoking and COPD Year: 2008 The influence of carboxyhemoglobin (COHb) generation on measured total lung diffusion capacity Source: Annual Congress 2012 - Life's a gas: aspects of respiratory gas exchange Year: 2012 Cut-off levels for exhaled carbon monoxide in smoking cessation program Source: Eur Respir J 2006; 28: Suppl. 50, 389s Year: 2006 Factors affecting exhaled carbon monoxide measurement as a biomarker of smoking Source: Annual Congress 2010 - Epidemiological data for smoking control Year: 2010 The effect on the single breath carbon monoxide transfer factor test after smoking one cigarette Source: Eur Respir J 2003; 22: Suppl. 45, 146s Year: 2003 The use of predicted vs actual haemoglobin in the calculation of gas transfer (TLCO) in lung cancer pathways Source: Virtual Congress 2020 – Localised non-small cell lung cancer Year: 2020 Detection of differences in volatile organic compounds (VOCs) by ion mobility spectrometry (IMS) of exhaled breath in patients with interstitial lung diseases (ILDs) compared to healthy controls (HC) Source: Annual Congress 2011 - Bronchoalveolar lavage and biomarkers in diffuse parenchymal lung disease Year: 2011